Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
WST West Pharmaceutical Services
- 213.460
- -2.660-1.23%
Close Apr 29 16:00 ET
- 213.460
- 0.0000.00%
Post 20:01 ET
15.34BMarket Cap33.51P/E (TTM)
217.590High213.260Low649.17KVolume216.060Open216.120Pre Close139.35MTurnover0.91%Turnover Ratio31.91P/E (Static)71.85MShares371.79652wk High5.72P/B15.22BFloat Cap187.43052wk Low0.82Dividend TTM71.32MShs Float471.465Historical High0.38%Div YieldTTM2.00%Amplitude3.185Historical Low214.664Avg Price1Lot Size
West Pharmaceutical Services Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.37%698M | -1.92%2.89B | 2.30%748.8M | -0.07%746.9M | -6.86%702.1M | -2.96%695.4M | 2.18%2.95B | 3.29%732M | 8.81%747.4M | -2.27%753.8M |
| Operating revenue | 0.37%698M | -1.92%2.89B | 2.30%748.8M | -0.07%746.9M | -6.86%702.1M | -2.96%695.4M | 2.18%2.95B | 3.29%732M | 8.81%747.4M | -2.27%753.8M |
| Cost of revenue | 0.19%466.1M | 4.07%1.89B | 4.72%475.2M | 5.03%482.2M | 2.10%472.1M | 4.47%465.2M | 3.99%1.82B | 1.61%453.8M | 9.60%459.1M | 2.80%462.4M |
| Gross profit | 0.74%231.9M | -11.57%998.5M | -1.65%273.6M | -8.19%264.7M | -21.07%230M | -15.15%230.2M | -0.62%1.13B | 6.14%278.2M | 7.57%288.3M | -9.36%291.4M |
| Operating expense | 0.00%104.3M | -3.37%407.6M | -4.24%103.8M | -6.07%99M | -4.19%100.5M | 1.16%104.3M | 12.36%421.8M | 6.69%108.4M | 31.91%105.4M | 9.38%104.9M |
| Selling and administrative expenses | 1.50%88M | -4.22%338.5M | -5.22%85.3M | -6.18%83.5M | -6.11%83M | 0.81%86.7M | 11.52%353.4M | 5.02%90M | 34.24%89M | 8.47%88.4M |
| Research and development costs | -7.39%16.3M | 1.02%69.1M | 0.54%18.5M | -5.49%15.5M | 6.06%17.5M | 2.92%17.6M | 16.92%68.4M | 15.72%18.4M | 20.59%16.4M | 14.58%16.5M |
| Operating profit | 1.35%127.6M | -16.47%590.9M | 0.00%169.8M | -9.40%165.7M | -30.56%129.5M | -25.15%125.9M | -7.02%707.4M | 5.79%169.8M | -2.76%182.9M | -17.33%186.5M |
| Net non-operating interest income expense | -19.57%3.7M | -12.63%16.6M | -31.71%5.6M | -33.90%3.9M | 8.70%2.5M | 76.92%4.6M | 778.57%19M | 583.33%8.2M | 942.86%5.9M | 264.29%2.3M |
| Non-operating interest income | -33.87%4.1M | -30.00%19.6M | -48.94%4.8M | -47.73%4.6M | -20.00%4M | 29.17%6.2M | 449.02%28M | 224.14%9.4M | 486.67%8.8M | 1,150.00%5M |
| Non-operating interest expense | -75.00%400K | -66.67%3M | -166.67%-800K | -75.86%700K | -44.44%1.5M | -27.27%1.6M | 13.92%9M | -29.41%1.2M | 31.82%2.9M | 50.00%2.7M |
| Other net income (expense) | -570.97%-20.8M | 22.54%-22M | -7.14%-10.5M | -183.33%-5.1M | 15.38%-3.3M | 75.97%-3.1M | 63.64%-28.4M | 70.30%-9.8M | 96.48%-1.8M | -230.00%-3.9M |
| Gain on sale of security | 0.00%-1.2M | -8.51%-10.2M | 54.69%-2.9M | -127.78%-4.1M | -566.67%-2M | -33.33%-1.2M | -329.27%-9.4M | -204.76%-6.4M | -357.14%-1.8M | -118.75%-300K |
| Special income (charges) | -1,093.75%-19.1M | 52.17%-9.9M | -386.67%-7.3M | 107.14%300K | 61.76%-1.3M | 86.21%-1.6M | 37.27%-20.7M | 95.07%-1.5M | -44.83%-4.2M | -409.09%-3.4M |
| -Less：Restructuring and merger&acquisition | 1,780.00%18.8M | 620.00%2.6M | 258.33%1.9M | -285.71%-1.3M | 433.33%1M | 233.33%1M | -101.87%-500K | -104.65%-1.2M | -53.33%700K | 76.92%-300K |
| -Less:Impairment of capital assets | -50.00%300K | ---- | ---- | ---- | ---- | -68.42%600K | ---- | ---- | ---- | ---- |
| -Write off | ---- | -23.96%7.3M | 100.00%5.4M | -71.43%1M | -80.00%300K | ---- | 54.84%9.6M | -41.30%2.7M | 150.00%3.5M | --1.5M |
| -Gain on sale of property,plant,equipment | ---- | --0 | --0 | --0 | --0 | ---- | ---11.6M | --0 | --0 | ---2.2M |
| Other non- operating income (expenses) | -66.67%-500K | -211.76%-1.9M | 84.21%-300K | -130.95%-1.3M | ---- | 25.00%-300K | 103.46%1.7M | -280.00%-1.9M | 108.57%4.2M | -166.67%-200K |
| Income before tax | -13.27%110.5M | -16.12%585.5M | -1.96%164.9M | -12.03%164.5M | -30.39%128.7M | -19.32%127.4M | 2.66%698M | 30.69%168.2M | 37.30%187M | -18.62%184.9M |
| Income tax | 46.95%24.1M | -12.10%107.5M | 6.67%36.8M | 10.20%32.4M | -37.07%21.9M | -30.51%16.4M | 6.63%122.3M | 19.38%34.5M | 44.12%29.4M | -21.27%34.8M |
| Earnings from equity interest net of tax | -20.93%3.4M | -16.95%14.7M | -39.39%2M | 5.41%3.9M | -10.00%4.5M | -24.56%4.3M | -14.49%17.7M | 3.13%3.3M | -22.92%3.7M | -9.09%5M |
| Net income | -22.12%89.8M | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M |
| Net income continuous Operations | -22.12%89.8M | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -22.12%89.8M | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -22.12%89.8M | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M |
| Basic earnings per share | -21.02%1.24 | -15.41%6.75 | -3.24%1.79 | -13.82%1.87 | -26.92%1.52 | -16.49%1.57 | 1.40%7.98 | 34.06%1.85 | 33.95%2.17 | -17.79%2.08 |
| Diluted earnings per share | -20.65%1.23 | -15.10%6.69 | -2.73%1.78 | -13.55%1.85 | -26.70%1.51 | -16.22%1.55 | 1.94%7.88 | 34.56%1.83 | 34.59%2.14 | -16.94%2.06 |
| Dividend per share | 5.00%0.21 | 5.19%0.81 | 5.00%0.21 | 5.26%0.2 | 5.26%0.2 | 5.26%0.2 | 5.48%0.77 | 5.26%0.2 | 5.56%0.19 | 5.56%0.19 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
